Sage Therapeutics, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Sage Therapeutics, Inc. reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $520.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-11.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2025-02-11
- Sage Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $520.00K, a 20.61% decline from fiscal 2023.
- Sage Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $655.00K, a 6.03% decline from fiscal 2022.
- Sage Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $697.00K, a 76.01% increase from fiscal 2021.
- Sage Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $396.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2024-12-31 | $520.00K 10-K · filed 2025-02-11 |
| 2023-12-31 | $655.00K 10-K · filed 2025-02-11 |
| 2022-12-31 | $697.00K 10-K · filed 2025-02-11 |
| 2021-12-31 | $396.00K 10-K · filed 2024-02-14 |
| 2013-12-31 | $1.40M 10-K · filed 2016-02-29 |